Earlier detection of public health risks - Health policy lessons for better compliance with the International Health Regulations (IHR 2005): Insights from low-, mid- and high-income countries.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
10 2019
Historique:
received: 02 12 2018
revised: 02 06 2019
accepted: 18 06 2019
pubmed: 11 7 2019
medline: 15 9 2020
entrez: 11 7 2019
Statut: ppublish

Résumé

The International Health Regulations (IHR 2005) require all Member States to build and maintain the capacities to prevent, detect and respond to public health emergencies. Early detection of public health risks is one of the core functions. In order to improve surveillance and detection, a better understanding of the health system conditions and their influencing factors are needed. The Israeli Ministry of Health/IHR National Focal Point held a workshop to elucidate health system conditions and their influencing factors that enable earlier detection. The workshop methodology employed a stepwise, small working group analysis approach to elucidate the conditions and their influencing factors affecting each stage of recognition, assessment, and reporting of infectious disease outbreaks, at the local, regional and national levels. In order to detect public health risks earlier, the detection process needs to be moved closer to the local communities and start with building capacity within communities. Building capacity and engaging with local and diverse communities requires significant changes in the governance approach and include information sharing, multi-sectoral communication and coordination across various levels before, during and after public health emergencies. Across the regions, low-, mid- and high-income countries seem to struggle more with governance and information sharing rather than with technical capacities and capabilities.

Identifiants

pubmed: 31288952
pii: S0168-8510(19)30157-5
doi: 10.1016/j.healthpol.2019.06.007
pmc: PMC7114645
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

941-946

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Lancet Infect Dis. 2014 Oct;14(10):1001-10
pubmed: 25189351
Lancet. 2015 Nov 28;386(10009):2222-6
pubmed: 26615327
Lancet. 2015 May 9;385(9980):1884-901
pubmed: 25987157
BMC Public Health. 2017 Jun 12;17(1):570
pubmed: 28606078
Sci Transl Med. 2015 Sep 30;7(307):307rv5
pubmed: 26424572
Front Public Health. 2020 Sep 11;8:452
pubmed: 33014967
Front Public Health. 2015 Oct 13;3:231
pubmed: 26528463
Health Secur. 2017 Jul/Aug;15(4):331-334
pubmed: 28745911
N Engl J Med. 2016 Mar 31;374(13):1281-7
pubmed: 26761419
Emerg Infect Dis. 2017 Dec;23(13):
pubmed: 29155676
Int J Infect Dis. 2016 Dec;53:15-20
pubmed: 27777092
Am J Public Health. 2016 Feb;106(2):279-82
pubmed: 26691130
Adv Exp Med Biol. 2017;972:131-139
pubmed: 28004307
Lancet. 2015 Jan 3;385(9962):29-35
pubmed: 25458732
Emerg Infect Dis. 2000 Mar-Apr;6(2):97-102
pubmed: 10756142

Auteurs

Bruria Adini (B)

Department of Emergency Management and Disaster Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Shepherd Roee Singer (SR)

Ministry of Health, Tel Aviv and Jerusalem, Israel; Hebrew University, Jerusalem, Israel.

Ronit Ringel (R)

Ministry of Health, Tel Aviv and Jerusalem, Israel.

Petra Dickmann (P)

Dickmann Risk Communication Drc|, London, UK; Jena University Hospital, Department of Anaesthesiology and Intensive Care, Jena, Germany. Electronic address: pdickmann@dickmann-drc.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH